Alok Industries (ALOKINDS) Q3 25/26 earnings summary
Event summary combining transcript, slides, and related documents.
Q3 25/26 earnings summary
15 Jan, 2026Executive summary
Unaudited consolidated and standalone financial results for the quarter and nine months ended December 31, 2025, were reviewed and approved by the Board and Audit Committee on January 15, 2026.
Statutory auditors issued unmodified opinions on both standalone and consolidated results, with no material misstatements identified.
Financial highlights
Standalone revenue from operations for the quarter was ₹807.03 crore, down from ₹901.19 crore in the previous quarter and ₹829.66 crore in the same quarter last year.
Standalone net loss for the quarter was ₹214.71 crore, compared to ₹201.97 crore in the previous quarter and ₹242.95 crore in the same quarter last year.
Consolidated revenue from operations for the quarter was ₹858.24 crore, down from ₹941.09 crore in the previous quarter and ₹870.63 crore in the same quarter last year.
Consolidated net loss for the quarter was ₹217.63 crore, compared to ₹162.38 crore in the previous quarter and ₹272.99 crore in the same quarter last year.
EBITDA loss for the quarter was ₹1.16 crore; EBITDA for the nine months was ₹60.30 crore.
Outlook and guidance
Management continues to prepare financial results on a going concern basis, citing internal improvements and external market conditions in cash flow projections.
Latest events from Alok Industries
- Consolidated Q2 FY26 loss narrows on revenue growth, positive EBITDA, and insurance gains.ALOKINDS
Q2 25/2616 Oct 2025 - Losses persist amid declining revenue, but positive EBITDA and improving market conditions support outlook.ALOKINDS
Q1 24/2526 Aug 2025 - Losses widened in Q2 FY25 amid lower revenue, but market conditions are reportedly improving.ALOKINDS
Q2 24/2526 Aug 2025 - Substantial losses persist amid improving market conditions and insurance recoveries.ALOKINDS
Q3 24/2526 Aug 2025 - FY25 saw continued losses, offset by asset gains and insurance, with improving market outlook.ALOKINDS
Q4 24/2526 Aug 2025 - Net losses persist amid declining revenues, with insurance recoveries boosting exceptional income.ALOKINDS
Q1 25/2626 Aug 2025